The Bill & Melinda Gates Medical Research Institute said it will use Matrix-M, the vaccine adjuvant used in Novavax’s Covid shot, to advance its “early-stage vaccine programs.”
The Bill & Melinda Gates Medical Research Institute said it will use Matrix-M, the vaccine adjuvant used in Novavax’s Covid shot, to advance its “early-stage vaccine programs.”